Infection Control Today - Tuberculosis

NIH Researchers Highlight Progress, Path Forward for Developing TB Vaccines

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those ...More

March 20, 2012

Posted in News

FDA Proposes Lower Risk Classification for Certain Tuberculosis Tests

The Food and Drug Administration (FDA) has issued a proposed rule today that would encourage the development of a type of test used to detect cases of tuberculosis (TB). This rule would lower the current risk classification for nucleic acid-based tests allowing ...More

March 19, 2012

Posted in News

TB Alliance Establishes New Pathway to TB and MDR-TB Treatment

In an ambitious effort to stem the dangerous tide of tuberculosis (TB) and deadly drug-resistant TB around the world, TB Alliance today announced that it has launched a first-of-its-kind clinical trial to test a novel drug combination – in both patients who have TB and ...More

March 19, 2012

Posted in News

Novel Tuberculosis Research Could Lead to New Treatments

According to the World Health Organization (WHO), one-third of the world's population is currently infected with tuberculosis bacteria. The bacteria is incredibly resistant to treatment, and despite its prevalence, very little is known about why it is so stress tolerant. ...More

February 15, 2012

Posted in News

Treatment for Tuberculosis Can be Guided by Patients' Genetics

A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis. An international collaboration between researchers at the University of Washington in Seattle, Duke University, Harvard ...More

February 8, 2012

Posted in News

Research Suggests New Way to Ensure Effectiveness of TB Treatment

A UT Southwestern Medical Center study using a sophisticated “glass mouse” research model has found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent doses, as is widely believed. If the study ...More

December 28, 2011